Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Trevena Trading Down 9.2% Shares of NASDAQ TRVN opened at $1.09 on Thursday. The stock has a 50 day simple […]
Investment analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Trevena Trading Down 9.2% Shares of NASDAQ TRVN opened at $1.09 on Thursday. The stock has a 50 day simple […]
-logo-1200x675.jpg?v=20230130112135&w=240&h=240&zc=2){kind=logo}
